Medtronic investigation
This article was originally published in The Gray Sheet
Executive Summary
Department of Justice sends a letter to Medtronic Nov. 16 requesting any information that the firm also is providing to the Securities and Exchange Commission related to SEC's investigation into possible violations of the U.S. Foreign Corrupt Practices Act, the firm notes in its Dec. 4 quarterly SEC filing. The firm says it is cooperating with DoJ and SEC. In September, SEC notified Stryker, Zimmer, Biomet, Smith & Nephew and Medtronic that it is investigating potential corrupt practices related to the companies' sales of devices in an unspecified number of countries including Greece, Poland and Germany (1"The Gray Sheet" Oct. 22, 2007, p. 10)
You may also be interested in...
Foreign Corrupt Practices Act: Device Industry Under Scrutiny
Federal prosecutors have begun targeting medical device companies in Foreign Corrupt Practices Act investigations
Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel
Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.
FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility
The US FDA’s device center has unveiled a new public dataset designed to assist chemistry laboratories in ensuring the robustness of chemical characterization methods used to assess the biocompatibility of medical devices.